We could not find any results for:
Make sure your spelling is correct or try broadening your search.
VANCOUVER, British Columbia, Feb. 26, 2015 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and...
VANCOUVER, British Columbia, Jan. 5, 2015 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced that Mr. Glen Ibbott has been appointed as the Interim...
VANCOUVER, British Columbia, Dec. 16, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is pleased to announce that, on a vote by ballot, the six incumbent...
VANCOUVER, British Columbia, July 14, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced the publication of data from its Phase 1b proof-of-concept...
VANCOUVER, British Columbia, April 30, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and...
VANCOUVER, British Columbia, Feb. 28, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and...
VANCOUVER, British Columbia, Feb. 27, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced positive preliminary results from its international...
VANCOUVER, British Columbia, Dec. 9, 2013 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced that the first patient has been dosed in the Company's...
Plans for Phase IIa Proof-of-Concept Trial for QLT091001 in Impaired Dark Adaptation Company to Provide Guidance on Pivotal Studies in Orphan Indications Before the End of Q1...
VANCOUVER, British Columbia, Nov. 11, 2013 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced that Vicente Anido, Jr. has resigned from the Board of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | FU |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | FU |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | FU |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | FU |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | FU |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | FU |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | FU |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions